Atlas Trials

A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

Clinical trial NCT00115167 · COMPLETED

Trial details

NCT number
NCT00115167
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AnemiaCancer
Start date
2004-08-01
Primary completion
2007-01-01
Enrollment
371

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.